Omeed Rahimi net worth
Quick answer
Omeed Rahimi's estimated net worth is $56K (range $39K – $84K) as of 2026. Omeed Rahimi is Founder at Encepheal Therapeutics. Encepheal Therapeutics valuation.
Omeed Rahimi is Founder at Encepheal Therapeutics (YC S19). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Inactive
- Education: Bachelor's degree from Stanford University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 3
- Website: http://www.encepheal.com
Who is Omeed Rahimi?
Omeed Rahimi is a co-founder of Encephal Therapeutics, a startup focused on developing innovative solutions for neurological disorders.
Highlights:
- Stanford University
- Tesla
About Encepheal Therapeutics
EncepHeal is developing medications to treat substance abuse. Our first product is a small molecule therapeutic for stimulants like cocaine and methamphetamine, of which there are no FDA approved treatments.
Our small molecule technology are atypical inhibitors of the dopamine transporter. Cocaine itself is an inhibitor of the same transporter. Directly reducing craving or positive reinforcement is a successful...
FAQ: Omeed Rahimi net worth and Encepheal Therapeutics valuation
What is Omeed Rahimi's net worth?
Omeed Rahimi's estimated net worth is $56K (range $39K – $84K) as of 2026. Omeed Rahimi is Founder at Encepheal Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Encepheal Therapeutics valuation?
Encepheal Therapeutics's estimated valuation on Entrepreneurial Check is $1.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Omeed Rahimi's role?
Omeed Rahimi is Founder at Encepheal Therapeutics, a Y Combinator-backed startup (batch S19).